|From: kyleLennon (Rep: 0)||Date: 06/13/2018 20:20|
|Forum: Galectin Therapeutics, Inc. - Msg #529||Thread #674015247 (Rec: 0) |
|S&P Captial deems that the stock in poor financial health. Financial Health leverages fundamental data to assess the company’s debt and interest obligations (among other factors), and financial health in comparison to its peers.|
Looking at the longer-term technical analysis, we concur that the near-term and long-term stock sentiment is also positive.
TheLion.com | About Us | Agreement & Disclaimer | Privacy | Twitter
© 1999- TheLion.com, Inc.